AbbVie
ABBV
#26
Rank
โ‚น36.704 T
Marketcap
โ‚น20,768
Share price
-0.45%
Change (1 day)
19.50%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น143.94 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น59.64 Billion. In 2024 the company made an earning of โ‚น337.82 Billion a decrease over its 2023 earnings that were of โ‚น568.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น143.94 B-57.39%
2024 โ‚น337.82 B-40.54%
2023 โ‚น568.20 B-53.62%
2022 โ‚น1.225 T3.76%
2021 โ‚น1.180 T282.25%
2020 โ‚น308.91 B-59.67%
2019 โ‚น766.02 B62.13%
2018 โ‚น472.46 B-32.74%
2017 โ‚น702.47 B-1.99%
2016 โ‚น716.75 B18.65%
2015 โ‚น604.11 B180.5%
2014 โ‚น215.37 B-55.57%
2013 โ‚น484.74 B-6.86%
2012 โ‚น520.46 B56.05%
2011 โ‚น333.51 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.077 T 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.045 T 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น749.47 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น173.09 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น898.75 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น730.29 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.190 T 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น847.56 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น53.01 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA